• Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration 

      Martínez-Maldonado, Alejandra; Ontiveros-Torres, Miguel Ángel; Harrington, Charles R.; Montiel-Sosa, José Francisco; Prandiz, Raúl García Tapia; Bocanegra-López, Patricia; Sorsby-Vargas, Andrew Michael; Bravo-Muñoz, Marely; Florán-Garduño, Benjamín; Villanueva-Fierro, Ignacio; Perry, George; Garcés-Ramírez, Linda; de la Cruz, Fidel; Martínez-Robles, Sandra; Pacheco-Herrero, Mar; Luna-Muñoz, José (IOS Press BV, 2021)
      Alzheimer's disease (AD) and progressive supranuclear palsy (PSP) are examples of neurodegenerative diseases, characterized by abnormal tau inclusions, that are called tauopathies. AD is characterized by highly insoluble ...
    • Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease 

      Apátiga‑Pérez, Ricardo; Soto‑Rojas, Luis O.; Campa‑Córdoba, B. Berenice; Luna‑Viramontes, Nabil Itzi; Cuevas, Elvis; Villanueva‑Fierro, Ignacio; Ontiveros‑Torres, Miguel Angel; Bravo‑Muñoz, Marely; Flores‑Rodríguez, Paola; Garcés‑Ramirez, Linda; de la Cruz, Fidel; Montiel‑Sosa, José Francisco; Pacheco‑Herrero, Mar; Luna‑Muñoz, José (Metabolic Brain Disease, 2021-07)
      Alzheimer's disease (AD) is clinically characterized by a progressive loss of cognitive functions and short-term memory. AD patients present two distinctive neuropathological lesions: neuritic plaques and neurofibrillary ...